The hypodermic syringes market is projected to grow from USD 3.9 billion in 2025 to USD 5.3 billion by 2035, at a CAGR of 3.2%. Polymer Syringes will dominate with a 54.3% market share, while manufacturers will lead the sales channel segment with a 47.6% share.